• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . B cell receptor repertoire analysis from autopsy samples of COVID-19 patients

tetano

Editor, Senior Moderator
Front Immunol


. 2023 Feb 23;14:1034978.
doi: 10.3389/fimmu.2023.1034978. eCollection 2023.
B cell receptor repertoire analysis from autopsy samples of COVID-19 patients


Sadahiro Iwabuchi[SUP] 1 [/SUP], Tomohide Tsukahara[SUP] 2 [/SUP], Toshitugu Okayama[SUP] 3 [/SUP], Masahiro Kitabatake[SUP] 4 [/SUP], Hideki Motobayashi[SUP] 5 [/SUP], Shigeyuki Shichino[SUP] 6 [/SUP], Tadashi Imafuku[SUP] 1 [/SUP], Kenzaburo Yamaji[SUP] 7 [/SUP], Kyohei Miyamoto[SUP] 8 [/SUP], Shinobu Tamura[SUP] 8 [/SUP], Satoshi Ueha[SUP] 6 [/SUP], Toshihiro Ito[SUP] 4 [/SUP], Shin-Ichi Murata[SUP] 9 [/SUP], Toshikazu Kondo[SUP] 10 [/SUP], Kazuho Ikeo[SUP] 3 [/SUP], Yutaka Suzuki[SUP] 11 [/SUP], Kouji Matsushima[SUP] 6 [/SUP], Michinori Kohara[SUP] 7 [/SUP], Toshihiko Torigoe[SUP] 2 [/SUP], Hiroki Yamaue[SUP] 5 12 [/SUP], Shinichi Hashimoto[SUP] 1 [/SUP]



Affiliations

Abstract

Neutralizing antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being developed world over. We investigated the possibility of producing artificial antibodies from the formalin fixation and paraffin-embedding (FFPE) lung lobes of a patient who died by coronavirus disease 2019 (COVID-19). The B-cell receptors repertoire in the lung tissue where SARS-CoV-2 was detected were considered to have highly sensitive virus-neutralizing activity, and artificial antibodies were produced by combining the most frequently detected heavy and light chains. Some neutralizing effects against the SARS-CoV-2 were observed, and mixing two different artificial antibodies had a higher tendency to suppress the virus. The neutralizing effects were similar to the immunoglobulin G obtained from healthy donors who had received a COVID-19 mRNA vaccine. Therefore, the use of FFPE lung tissue, which preserves the condition of direct virus sensitization, to generate artificial antibodies may be useful against future unknown infectious diseases.

Keywords: B cell receptors; COVID-19; lung; serum IgGs; single cell; vaccine intake.
 
Back
Top Bottom